Vector Clinical Trials

Vector Clinical Trials is a clinical research site organization based in Savannah, Georgia, that specializes in conducting Phase II through Phase IV clinical trials. The company provides comprehensive trial management services across a variety of therapeutic areas, with a strong emphasis on vaccines, infectious diseases, and internal medicine. In August 2022, Vector Clinical Trials was acquired by Centricity Research, one of the largest integrated clinical research site networks in North America. This acquisition integrated Vector's regional expertise and high-performing site into Centricity's broader platform to enhance patient recruitment and trial execution capabilities in the Southeast United States. The company continues to operate as a key site within the Centricity Research network, delivering high-quality data for pharmaceutical and biotechnology sponsors.